Skip to main content
Synthetic and Systems Biotechnology logoLink to Synthetic and Systems Biotechnology
. 2021 Aug 10;6(3):200–208. doi: 10.1016/j.synbio.2021.08.001

A CRISPR/Cas9-based single-stranded DNA recombineering system for genome editing of Rhodococcus opacus PD630

Youxiang Liang a,b,1, Yuwen Wei a,b,1, Song Jiao c, Huimin Yu a,b,d,
PMCID: PMC8365321  PMID: 34430726

Abstract

Genome engineering of Rhodococcus opacus PD630, an important microorganism used for the bioconversion of lignin, is currently dependent on inefficient homologous recombination. Although a CRISPR interference procedure for gene repression has previously been developed for R. opacus PD630, a CRISPR/Cas9 system for gene knockout has yet to be reported for the strain. In this study, we found that the cytotoxicity of Cas9 and the deficiency in pathways for repairing DNA double-strand breaks (DSBs) were the major causes of the failure of conventional CRISPR/Cas9 technologies in R. opacus, even when augmented with the recombinases Che9c60 and Che9c61. We successfully developed an efficient single-stranded DNA (ssDNA) recombineering system coupled with CRISPR/Cas9 counter-selection, which facilitated rapid and scarless editing of the R. opacus genome. A two-plasmid system, comprising Cas9 driven by a weak Rhodococcus promoter Pniami, designed to prevent cytotoxicity, and a single-guide RNA (sgRNA) under the control of a strong constitutive promoter, was proven to be appropriate with respect to cleavage function. A novel recombinase, RrRecT derived from a Rhodococcus ruber prophage, was identified for the first time, which facilitated recombination of short ssDNA donors (40–80 nt) targeted to the lagging strand and enabled us to obtain a recombination efficiency up to 103-fold higher than that of endogenous pathways. Finally, by incorporating RrRecT and Cas9 into a single plasmid and then co-transforming cells with sgRNA plasmids and short ssDNA donors, we efficiently achieved gene disruption and base mutation in R. opacus, with editing efficiencies ranging from 22 % to 100 %. Simultaneous disruption of double genes was also confirmed, although at a lower efficiency. This effective genome editing tool will accelerate the engineering of R. opacus metabolism.

Keywords: Rhodococcus opacus, CRISPR/Cas9, ssDNA recombineering, Novel recombinase, Genome editing

1. Introduction

Rhodococcus opacus PD630, a non-model gram-positive oleaginous bacterium, is of considerable commercial interest with respect to the conversion of lignin to value-added products such as biofuels and muconate [[1], [2], [3]]. R. opacus can tolerate aromatic compounds derived from the pre-treatment and depolymerization of lignin [4], and has diverse enzymatic pathways that contribute to the degradation and assimilation of aromatics. In addition, R. opacus can accumulate triacylglycerols to high levels of up to 78 % of the cell dry weight [5]. These desirable traits make R. opacus an attractive option for lignin conversion and biofuel production, and in this regard, diverse genetic toolkits have recently been developed for this bacterium [[6], [7], [8]], although there remains a necessity for efficient genome editing tools.

Single-crossover integration of non-replicating plasmids is a typical gene disruption technique used for R. opacus. Furthermore, to recover antibiotic selection markers from the genome, a two-step crossover can be employed using a counter-selection marker, such as sacB or pheS* [2,3]. However, illegitimate recombination has been reported in Rhodococcus in response to the introduction of non-replicating plasmids, resulting in random integration and low editing efficiency [9]. In conjunction with the use of recombinases Che9c60 and Che9c61, derived from a mycobacteriophage [10], a recombination method based on a linear double-stranded DNA (dsDNA) template flanking an antibiotic selection marker has been developed for R. opacus, which has contributed to enhancing editing efficiency [6]. However, the antibiotic selection marker used in this procedure is non-recyclable, thereby limiting the number of multiple rounds of editing.

The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) system has been developed as a powerful tool for genome editing in both eukaryotes and prokaryotes [11,12]. The complex of DNA nuclease Cas9 and single-guide RNA sequences (sgRNAs) can introduce DNA double-strand breaks (DSBs) at a target locus with a protospacer adjacent motif (PAM) [11]. Gene editing will be achieved by repairing DSBs through non-homologous end joining (NHEJ) or homologous recombination (HR) [13]. Using a catalytically inactive mutant of Cas9 nuclease (dCas9), CRISPR can be repurposed as an interference system (CRISPRi) for gene repression [14]. However, although a CRISPRi system has previously been developed for R. opacus engineering [6], attempts to develop a CRISPR/Cas9 system for gene knockout, which additionally requires efficient pathways for DSB repair, have not been reported yet. Moreover, despite the establishment of a CRISPR/Cas9-mediated dsDNA recombineering system for another Rhodococcus species, R. ruber [15], this method has proved unviable in the case of R. opacus.

With respect to the development of CRISPR/Cas9 systems in prokaryotes, the introduction of recombinases derived from bacteriophages or prophages is usually a necessary prerequisite, owing to the limited efficiency of endogenous NHEJ or HR pathways for DSB repair [12]. Classical recombinases include beta, exo, and gamma proteins of the λ Red system [16], and RecE and RecT of the Rac prophage [17]. However, these proteins are not broadly portable and only function in a small group of phylogenetically related species [18]. To address this problem, a reliable strategy is the screening of recombinases derived from phages or prophages that infect the host of interest [19].

In this study, we initially fine-tuned the expression of the cas9 gene and enabled the function of the Cas9-sgRNA complex to introduce DSBs in R. opacus for counter-selection. To compensate for the inefficient DSB repair pathways in R. opacus, we further screened and obtained a novel recombinase RrRecT from an R. ruber prophage for single-stranded DNA (ssDNA) recombineering. Using CRISPR/Cas9 for counter-selection, we developed an efficient ssDNA recombineering system for rapid and scarless genome editing in R. opacus with editing efficiencies ranging from 22 % to 100 %, and demonstrated its potential utility for one-step multiple gene disruption.

2. Material and methods

2.1. Strains and media

The plasmids and strains used in this study are listed in Table S1. For plasmid construction, we used Escherichia coli Top 10. Luria-Bertani (LB) medium (10 g tryptone, 5 g yeast extract, and 10 g NaCl per liter) was used for the cultivation of E. coli. Seed medium (20 g glucose, 1 g yeast extract, 7 g tryptone, 0.5 g KH2PO4, 0.5 g K2HPO4·3H2O, 0.5 g MgSO4·7H2O, and 1 g monosodium glutamate per liter, pH 7.5) was used for liquid culture of R. opacus, and solid medium (10 g glucose, 3 g yeast extract, 1 g NaCl, 2 g K2HPO4·3H2O, 0.2 g MgSO4·7H2O, and 15 g agar per liter, natural pH) was used for plate culture. When required, 25 μg/mL kanamycin, 10 μg/mL chloramphenicol, or 12 μg/mL rifampicin were added to the medium.

2.2. Plasmid construction

The plasmids pNV-Pa2-Cas9, pNV-null-Cas9, and pBNVCm-BbsI-sgRNA were constructed in our previous study, in which we developed a CRISPR/Cas9 system for R. ruber [15]. For construction of the plasmid pNV-Pniami-Cas9, Pniami promoter was amplified from the R. ruber genome using primers HindIII-Pniami-F and XbaI-Pniami-R, and then ligated to plasmid pNV-null-Cas9. The primers used in this study are shown in Table S2, and sequences of the promoters and cas9 genes are listed in Table S3.

The pBNVCm-sgRNA plasmids were constructed using the Golden Gate Assembly method. For example, to generate pBNVCm-07156-sgRNA, primers 07156-sgRNA-F and 07156-sgRNA-R were annealed to form dsDNA with sticky ends and then ligated to the BbsI-digested pBNVCm-BbsI-sgRNA. For the construction of the plasmid pBNVCm-07156-sgRNA-donor, upstream and downstream homologous arms of the LPD07156 gene were amplified from the R. opacus genome using primers 07156-up-F/R, and 07156-down-F/R, respectively, and then ligated to plasmid pBNVCm-07156-sgRNA via Gibson Assembly. Similarly, the upstream and downstream homologous arms of the LPD02538 gene were amplified from the R. opacus genome using the primers 02538-up-F/R and 02538-down-F/R, respectively, and then ligated to plasmid pBNVCm-02538-sgRNA, to generate pBNVCm-02538-sgRNA-donor. For the construction of pBNVCm-03951-01628-sgRNA, the sgRNA cassette targeting LPD01628 was amplified from plasmid pBNVCm-01628-sgRNA using the primers KpnI-sgRNA-F and EcoRI-sgRNA-R, and ligated to the pBNVCm-03951-sgRNA plasmid via Gibson Assembly.

For the construction of plasmids containing recombinase genes, such as pNV-PBAD-D, we initially amplified the promoter PBAD from pKD46 [16] using the primers HindIII-PBAD-F and XbaI-PBAD-R, and then ligated this to the pNV18.1 plasmid [20] to generate plasmid pNV-PBAD. The gene encoding recombinase D, commercially synthesized by GENEWIZ (Suzhou, China), was amplified using primers XbaI-D-F and KpnI-D-R, and subsequently ligated to the pNV-PBAD plasmid to generate pNV-PBAD-D. Furthermore, PBAD-D was amplified from pNV-PBAD-D using primers PBAD-F and D-R2, terminators rrnBT1 and rrnBT2 were amplified from pXMJ19 [21] using primers Ter-F and Ter-R, and the two fragments were then ligated with the HindIII-digested pNV-Pniami-Cas9 via Gibson Assembly, to construct plasmid pNV-PBAD-D-Pniami-Cas9. The sequences of the promoter PBAD, recombinase genes, and terminators are listed in Table S3.

DNA polymerases and T4 DNA ligases were purchased from Vazyme (Nanjing, China), restriction enzymes were purchased from Takara (Shiga, Japan), and Gibson Assembly kits were purchased from Taihe Biotechnology (Beijing, China). Plasmid extraction, DNA purification, and gel extraction kits were purchased from Omega (USA), and DNA sequencing and primer synthesis were performed by GENEWIZ (Suzhou, China). To achieve high cleavage efficiency and reduce potential off-targeting effects, the guide sequences of sgRNAs were designed using a web-based tool, called Cas-Designer [22].

2.3. Transformation protocol for R. opacus

For the preparation of competent cells, R. opacus was cultivated in seed medium for 48 h at 28 °C and 200 rpm, and then inoculated into 100 mL of nutrient broth medium (10 g/L peptone, 5 g/L NaCl, and 3 g/L beef extract, pH 7.2) containing 8.5 g/L glycine and 10 g/L sucrose, with an initial OD600 of 0.05 [23]. Cells were grown at 28 °C and 200 rpm to an OD600 of 0.5, and then centrifuged at 8000×g for 20 min at 4 °C. The pellet thus obtained was washed twice with pre-cooled deionized water (4 °C) and finally concentrated 50-fold. For routine transformation of plasmids, 200 μL of competent cells was mixed with 1 μg of plasmids and then loaded into an electroporation cuvette with a 0.2 cm gap. After cooling for 10 min on ice, electroporation was performed using a pulse of 10 kV/cm. Cells were immediately mixed with 800 μL of LBHIS medium (5 g tryptone, 5 g NaCl, 2.5 g yeast extract, 18.5 g brain heart infusion powder, and 91 g sorbitol per liter), incubated at 28 °C and 200 rpm for 4–5 h, and thereafter spread on solid medium containing appropriate antibiotics. Cells were grown at 28 °C for 2–4 days until visible colonies were obtained.

2.4. Screening and optimization of recombinases for ssDNA recombineering

To determine the rpoB gene mutations responsible for the rifampicin-resistant phenotype, R. opacus was cultivated in seed medium for 48 h, and 200 μL of the culture broth was subsequently spread on solid medium containing rifampicin. The cells were incubated at 28 °C for 3 days, and then four rifampicin-resistant colonies were randomly picked for PCR with primers rpoB-F and rpoB-R. The PCR products were sequenced and aligned with the wild-type rpoB gene to determine the mutations resulting in rifampicin resistance.

The plasmids pNV-PBAD-A/B/C/D/E/Che9c61 containing recombinase genes, as well as the empty plasmid pNV-PBAD were transformed to R. opacus. For the preparation of competent cells, 10 mmol/L arabinose was added when the OD600 of the culture reached 0.25–0.3, and then the recombinases were induced for 3–4 h until attaining an OD600 of 0.5. R. opacus harboring recombinases was transformed with 5 μg of oligonucleotides S464F–F and S464F-R, recovered in LBHIS medium for 5 h, and spread on rifampicin plates. The colonies thus obtained were counted and compared to determine the recombinase with the highest efficiency. Furthermore, we optimized the protocol for ssDNA recombineering in R. opacus (pNV-PBAD-D) with respect to arabinose inducer concentration and the amount and length of ssDNA.

2.5. Protocol of CRISPR/Cas9-based ssDNA recombineering

To combine CRISPR/Cas9 with ssDNA recombineering, we transformed plasmid pNV-PBAD-D-Pniami-Cas9 to R. opacus. The resulting strain was induced using 10 mmol/L arabinose during competent cell preparation for the expression of recombinase RrRecT. For genome editing, R. opacus (pNV-PBAD-D-Pniami-Cas9) competent cells (200 μL) were transformed with 2 μg of pBNVCm-sgRNA series plasmids and 10 μg of corresponding oligonucleotides, recovered for 5 h, spread on solid medium containing kanamycin and chloramphenicol, and then incubated at 28 °C for 3 or 4 days. Colonies were examined based on PCR analyses using appropriate primers, and when necessary, positive colonies were further sequenced to confirm editing.

2.6. Curing of plasmids

For multiple rounds of genome editing, previously introduced sgRNA plasmids must be cured prior to the introduction of a further plasmid. To cure sgRNA plasmids, edited colonies were cultivated for 2 days at 28 °C in seed medium containing kanamycin, and then spread on solid medium containing kanamycin. After incubation at 28 °C for 2 days, colonies were inoculated onto plates containing chloramphenicol. Those colonies unable to grow on chloramphenicol were identified as those lacking pBNVCm-sgRNA, and they were selected for the subsequent round of editing. Having completed the final round of editing, the plasmids pNV-PBAD-D-Pniami-Cas9 and pBNVCm-sgRNA could be simultaneously cured when cells were cultured and spread on plates lacking antibiotics.

3. Results

3.1. Fine-tuning of Cas9 expression for efficient function in R. opacus PD630

In order to develop a CRIPSR/Cas9 genome editing system applicable to R. opacus PD630, we initially needed to enable the function of the Cas9-sgRNA complex to introduce DSBs in the target genomic locus. To this end, we designed a two-plasmid system, one for Cas9 expression and the other for sgRNA transcription, to examine the function of the Cas9-sgRNA complex, as shown in Fig. 1a.

Fig. 1.

Fig. 1

Verification of the cleavage function of the Cas9-sgRNA complex in R. opacus. (a) The experimental scheme used to generate a Cas9-sgRNA complex designed to introduce double-strand breaks in the target genomic locus in R. opacus. (b) The transformation efficiency of Cas9 plasmids in which Cas9 was driven by different promoters. (c) The transformation efficiency of sgRNA plasmids to R. opacus with or without plasmid pNV-Pniami-Cas9. Plasmids pBNVCm-07156-sgRNA, pBNVCm-02538-sgRNA and pBNVCm-03951-sgRNA contained sgRNAs targeting genes LPD07156, LPD02538, and LPD03951, respectively. The sgRNA-deficient plasmid pBNVCm was used as a control and experiments were performed in triplicate.

Previously, we constructed the pNV-Pa2-Cas9 plasmid [15], in which a codon-optimized cas9 gene was driven by the urea-inducible Pa2 promoter [24], for genome editing in R. ruber. However, we found the Pa2 promoter acted as a strong constitutive promoter in R. opacus. This can be attributed to the fact that although transcriptional regulators of Pa2 are located in the R. ruber genome, they are not present in that of R. opacus. The strong constitutive overexpression of Cas9 driven by Pa2 would conceivably be lethal to R. opacus and prevent pNV-Pa2-Cas9 transformation. We accordingly found that the transformation efficiency of pNV-Pa2-Cas9 was 345-fold lower than that of pNV-null-Cas9 lacking a promoter for Cas9 (as shown in Fig. 1b). Subsequently, colony PCR of the resulting colonies failed to generate the intact cas9 gene fragment (see Fig. S1). Given these observation, we therefore replaced the Pa2 promoter with a 20-fold weaker promoter, Pniami [24], and constructed a new plasmid, pNV-Pniami-Cas9, which was successfully transformed to R. opacus at high efficiency (see Fig. 1b).

The sgRNA cassette was transcribed under the control of a strong constitutive promoter, PamiC, and inserted into the temperature-sensitive plasmid pBNVCm [15]. To verify the function of the Cas9-sgRNA complex, the pBNVCm-sgRNA series of plasmids were introduced into R. opacus strains both with and without pNV-Pniami-Cas9. In the present study, we selected several genes for sgRNA design, namely, LPD07156 encoding a benzoate transport protein, LPD02538 encoding a restriction enzyme, and LPD03951 encoding a DNA repair protein, the functions of which are assumed to be non-essential in R. opacus. Sequences of these genes were obtained from GenBank P003949.1, which contains the whole genome sequences of R. opacus PD630. Compared with wild-type R. opacus, we found that the transformation efficiencies of the pBNVCm-sgRNA plasmids to R. opacus harboring Cas9 were reduced by ~103 fold, as shown in Fig. 1c, thereby indicating that the Cas9-sgRNA complex functions efficiently in R. opacus for counter-selection.

3.2. The endogenous HR and NHEJ pathways were insufficiently efficient for DSB repair in R. opacus PD630

To verify the editing efficiency of the CRISPR/Cas9 system, we selected gene LPD07156 encoding a benzoate transport protein for knockout. This gene has been reported to be non-essential, based on deletion using an alternative method [25]. The homologous arms of LPD07156 (750 bp each side) were cloned into plasmid pBNVCm-07156-sgRNA to construct pBNVCm-07156-sgRNA-donor, which was introduced into R. opacus PD630 (pNV-Pniami-Cas9) for gene knockout. However, we found that the homologous recombination (HR) efficiency of R. opacus was insufficient for DSB repair, and the editing efficiency via HR was 0/23 (0 %), as shown in Fig. 2. Knockout of a further gene, LPD02538, encoding a restriction enzyme, using plasmid pBNVCm-02538-sgRNA-donor, proved similarly ineffective with an editing efficiency of 0/23, as shown in Fig. S2. These findings regarding the low efficiency of DSB repair via endogenous HR pathways in R. opacus are consistent our observations on R. ruber [15].

Fig. 2.

Fig. 2

Double-strand break repair pathways in R. opacus for gene knockout using the CRISPR/Cas9 system. If the DSB of LPD07156 was repaired by homologous recombination (HR), 491 bp would be deleted from the genome. When using primers P1 and P2 for PCR, DNA fragments of 1698 bp and 1207 bp should be amplified from the wild-type and edited colonies, respectively. To verify potential DSB repair mediated by non-homologous end joining (NHEJ), 10 colonies were randomly selected for PCR using primers P1 and P2, and the products were sequenced and aligned to the LPD07156 gene.

Interestingly, when sequencing the target site of the LPD07156 gene recognized by the sgRNA, we found that three of the 10 randomly selected colonies showed deletions of different lengths ranging from 34 to 310 bp, as shown in Fig. 2. We speculate that this phenomenon can probably be attributed to the NHEJ pathway in R. opacus. In prokaryotes, the NHEJ pathway typically comprises two core elements, namely, Ku, a DNA end-joining protein, and the ATP-dependent DNA ligase LigD [26]. BLAST search results using Ku and LigD from Mycobacterium smegmatis [27] as queries revealed the presence of the NHEJ pathway in R. opacus PD630, as shown in Fig. S3. However, when we examined the effects of more sgRNAs, we found that the efficiency of DSB repair mediated by NHEJ was dependent to a considerable extent on the nature of the target site, as summarized in Table 1. For most sgRNAs, we were unable to detect either insertions or deletions, which thus tended to indicate that similar to the HR pathway, the endogenous NHEJ pathway in R. opacus was insufficiently efficient for DSB repair. Most of the surviving colonies were escapers that mutated the cas9 gene or sgRNA cassette, thereby blocking the cleavage function of Cas9-sgRNA complex [15].

Table 1.

Editing efficiency for assessed genes based on endogenous NHEJ.

Gene IDa Guide sequence of sgRNAb Editing efficiency by NHEJc
LPD07156 GTGAGTACGCGTCGAACCGCTGG 3/10
LPD02538 CCTCCTCTGGCCAGCGCTTCAGG 0/24
LPD03951 GAAGAGTTACTTCCTCGAACCGG 3/11
LPD01620 CCGCTTCCACCGTCTCCTGCCGG 0/16
LPD01622 CAGGATCGTCAGCGCATTGCAGG 0/16
LPD01628 ATCTGCAACGGTTCCCGGACGGG 0/16
a

LPD01620 encodes a subunit of gramicidin synthase and LPD01628 encodes an ATP-dependent DNA ligase.

b

The guide sequence was designed using a web-based tool [22].

c

Number of edited colonies/number of examined transformants.

3.3. Screening of Rhodococcus phage- or prophage-derived recombinases for ssDNA recombineering

Given that we found the endogenous recombination pathways in R. opacus to be inefficient for DSB repair, we further attempted to introduce an exogenous recombinase to facilitate recombination in R. opacus. In this regard, DeLorenzo et al. have reported a dsDNA recombineering method for gene knockout in R. opacus based on the use of the mycobacteriophage recombinases Che9c60 and Che9c61 [6]. In our previous study, we similarly utilized these two recombinases to develop a CRISPR/Cas9-based dsDNA recombination system for R. ruber [15]. However, we found that the same method was not applicable for R. opacus, as the recombination efficiencies obtained using Che9c60 and Che9c61 differed notably between R. ruber and R. opacus. Comparatively, whereas approximately 200 colonies were obtained for R. ruber [15] when using Che9c60 and Che9c61 to facilitate recombineering of dsDNA templates flanking antibiotic resistance markers, only 2 to 4 colonies could be obtained for R. opacus [6]. Such low dsDNA recombineering efficiency using Che9c60 and Che9c61 would be insufficient for DSB repair in R. opacus, and consequently it will be necessary to identify a more efficient system for engineering R. opacus.

Compared with dsDNA, recombineering of ssDNA provides a more convenient means of performing genome modification, as it requires only short oligonucleotides as templates and eliminates the need for PCR amplification of long homologous arms. To facilitate highly efficient ssDNA recombineering in R. opacus, we searched the UniProt database (https://www.uniprot.org/) for novel recombinases specifically derived from Rhodococcus phages and prophages. We accordingly identified five potential recombinases containing a RecT family domain as summarized in Table 2, and synthesized the corresponding genes based on the codon preference of R. opacus for further assessment, together with the previously reported Che9c61. The protein sequence alignment results are presented in Fig. S4.

Table 2.

The recombinases charaterized in this study.

Recombinase Entry Length (aa) Source
A A0A260VZP4 339 Rhodococcus sp. 14-2470-1a
B A0A2U8UJ13 292 Rhodococcus phage Jace
C A0A285E014 379 Rhodococcus sp. OK270
D A0A098BJR0 618 R. ruber
E A0A515MHE2 387 Rhodococcus phage Sleepyhead
Che9c61 Q854T9 353 Mycobacterium virus Che9c

It has been reported that certain mutations in the β subunit of RNA polymerase can result in rifampicin resistance of some bacteria [19]. This phenomenon has also been utilized for the assessment of ssDNA recombineering efficiency, which involves mutating the RNA polymerase gene (rpoB) with desgined single-stranded oligonucleotides and counting the rifampicin-resistant colonies [19]. To determine the mutations responsible for rifampicin resistance, we sequenced the rpoB genes of four spontaneous resistant R. opacus colonies, and thereby established that all were characterized by a C·G to T·A base mutation resulting in mutation of the 464th residue from a Ser to Phe, as shown in Fig. 3a. On the basis of these observations, we designed and synthesized two 80-nt single-stranded oligonucleotides (S464F–F and S464F-R) as ssDNA donors (complementary to the leading and lagging strand of the rpoB gene but containing a mutation in the central sequence) for the assessment of ssDNA recombineering efficiency.

Fig. 3.

Fig. 3

Screening of recombinases and optimization of the ssDNA recombineering protocol. (a) Determination of the rpoB gene mutations responsible for rifampicin resistance. (b) The experimental scheme to assess the ssDNA recombineering efficiency of recombinases. (c) Selection of exogenous recombinases for ssDNA recombination. R. opacus harboring recombinases were induced with 10 mM arabinose for 3–4 h during competent cell preparation. Oligonucleotides S464F–F and S464F-R with a length of 80 nt and amount of 5 μg were introduced. (d) Optimization of arabinose concentration for the induction of recombinase RrRecT. The amout and length of oligonucleotide S464F-R was 5 μg and 80 nt, respectively. (e) Optimization of ssDNA amount. The arabinose concentration was 10 mM, and the length of oligonucleotide S464F-R was 80 nt. (f) Optimization of ssDNA length. The arabinose concentration was 10 mM, and the amount of oligonucleotide S464F-R was 25 μg. The sequences of oligonucleotides were shown in Tables S4. Experiments were performed in triplicate.

The five recombinase genes, along with the che9c61 gene, were cloned into the pNV18 plasmid under the control of the PBAD arabinose-inducible promoter [16], which were transformed to R. opacus. Having induced the resulting recombinant strains using arabinose, the oligonucleotides S464F–F and S464F-R were introduced to mutate the rpoB gene, followed by spreading on rafampicin-containing medium for colony counting. As shown in Fig. 3c, the highest recombination efficiency was obtained using recombinase D derived from an R. ruber prophage with oligonucleotide S464F-R as the ssDNA donor. Contrastingly, the empty vector control bacteria dependent on endogenous pathways showed no evidence of recombination. Furthermore, compared with S464F-R, the S464F–F oligonucleotide proved relatively ineffective for ssDNA recombineering, thereby indicating a strong bias toward ssDNA targeted to the lagging strand. On the basis of these observations, we thus used the novel recombinase D (which we named RrRecT) in combination with the oligonucleotide S464F-R for further optimization of ssDNA recombineering.

With regards to optimizing the newly developed system, we examined the effects of arabinose concentration for RrRecT induction during the preparation of competent cells, the amount of ssDNA used for electropoation, and ssDNA length, the results of which are shown in Fig. 3d, 3e, and 3f, respectively. On the basis of these assessments, we used an arabinose concentration of 10 mM and an ssDNA amount and length of 25 μg and 60–80 nt, respectively, for optimized evaluations. As a consequence of optimization, we obtained an RrRecT-mediated ssDNA recombineering efficiency that was 103-fold higher than that obtained based on endogenous pathways.

3.4. RrRecT-mediated ssDNA recombination with CRISPR/Cas9 counter-selection for gene knockout

We subsequently assessed the efficacy of ssDNA recombineering combined with the CRISPR/Cas9 system for genome editing in R. opacus. As an initial step, we constructed the pNV-PBAD-D-Pniami-Cas9 plasmid harboring the cas9 gene and the recombinase RrRecT gene, and used this to transform R. opacus. For the purposes of gene knockout, we subsequently introduced pBNVCm-sgRNA series plasmids and the corresponding oligonucleotides, as shown in Fig. 4a. The recombinase can facilitate the annealing of oligonucleotides to the target sites as primers for Okazaki fragments during replication, thereby resulting in the loss of sgRNA binding or PAM sequences. Moreover, the Cas9-sgRNA complex can recognize and cleave the target genomic locus in unedited genomes, thus implementing counter-selection.

Fig. 4.

Fig. 4

The CRISPR/Cas9-based ssDNA recombineering system for genome editing in R. opacus. (a) A schematic diagram illustrating the mechanism of the system. Plasmid pNV-PBAD-D-Pniami-Cas9 harboing the recombinase RrRecT and Cas9 was initially introduced into R. opacus, and cells were then co-transformed with a series of pBNVCm-sgRNA plasmids and olignonucleotides. (b) Gene knockout of LPD07156. Edited genomes would lose 2 base pairs in the PAM site of LPD07156 targeted by sgRNA. Primers P3 matched the altered sequence in the edited genome although not the wild-type sequence. Primers P3 and P2 could amplify a fragment of 197 bp from the edited genome. The deletion was also confirmed by Sanger sequencing of the fragments.

To verify the efficiency of the system, we selected the LPD07156 gene as a target gene for knockout. We designed a single-stranded oligonucleotide that would delete two base pairs in the PAM sequence of LPD07156, which was used to introduce a frame shift mutation in the gene. The editing efficiency of ssDNA recombineering was accordingly found to be 8/23 (35 %), as shown in Fig. 4b, thereby confirming the efficacy of the system for precise genome editing. We also examined the knockout of several other genes, for which we achieved editing efficiencies ranging from 22 % to 75 % (see Table 3), thereby demonstrating the robustness of the system for genome editing. In addition, we investigated the effect of deletion length on editing efficiency, and accordingly found that the efficiency obtained for a 2-bp deletion in LPD03951 reached 75 %, whereas efficiencies decreased to 25 % for 100- and 500-bp deletions, and to 0 % for a 1000-bp deletion. We also examined the effect of a single base mutation in LPD03951 (alteration of the PAM site from CGG to CCG to avoid recognition), and accordingly achieved an editing efficiency up to 100 %. These observations thus indicate that this system is effective for single-base mutations and short fragment deletions, but is less efficient when longer fragment are deleted.

Table 3.

Gene editing using the CRISPR/Cas9-based ssDNA recombineering system.

Gene Guide sequence of sgRNA Oligonucleotidea Deletion length Editing efficiency
LPD07156 GTGAGTACGCGTCGAACCGCTGG Oligo-07156 2 8/23 (35 %)
LPD02538 CCTCCTCTGGCCAGCGCTTCAGG Oligo-02538 2 5/16 (31 %)
LPD01620 CCGCTTCCACCGTCTCCTGCCGG Oligo-01620 2 5/23 (22 %)
LPD01628 ATCTGCAACGGTTCCCGGACGGG Oligo-01628 2 11/23 (48 %)
LPD03951 GAAGAGTTACTTCCTCGAACCGG Oligo-03951-1 2 15/20 (75 %)
Oligo-03951-2 20 23/31 (74 %)
Oligo-03951-3 100 5/20 (25 %)
Oligo-03951-4 500 5/20 (25 %)
Oligo-03951-5 1000 0/20 (0 %)
Oligo-03951-6 Point mutation 36/36 (100 %)
a

Sequences of the single-stranded oligonucleotides are listed in Table S4.

To verify the feasibility of double gene knockout, we introduced the plasmid pBNVCm-03951-01628-sgRNA (see Fig. S5) containing tandem sgRNAs targeting the genes LPD03951 and LPD01628, along with the corresponding oligonucleotides oligo-03951-1 and oligo-01628. As the editing of LPD03591 or LPD01628 was affected by the introduction of an additional sgRNA cassette, their editing efficiencies in the double gene knockout experiment were lower than that in single knockout experiments. The editing efficiencies for LPD03951 and LPD01628 were accordingly found to be 12/72 (16.7 %) and 3/72 (4.2 %), respectively, as shown in Fig. S6. Three of the 72 colonies obtained showed simultaneous disruption of the two genes, thus indicating the potential of the CRISPR/Cas9-based ssDNA recombineering system for one-step multiple gene inactivation. At present, however, the efficiency of this double gene knockout system is insufficient for practical purposes, and will thus necessitate further optimization.

3.5. An iterative genome editing protocol for R. opacus

For the purpose of conducting multiple rounds of genome editing, we further developed an iterative protocol for R. opacus (as shown in Fig. 5), which entails curing of the sgRNA plasmid after successive rounds of editing. In our design, the pB264 replicon used in construction of the pBNVCm-sgRNA plasmids is temperature-sensitive and can be readily cured when R. opacus is cultured at 37 °C in the absence of chloramphenicol. At this temperature, however, R. opacus PD630 has a significantly lower rate of growth than at 28 °C, as shown in Fig. S7. Thus, we assessed the effect of curing sgRNA plasmids at 28 °C. Unexpectedly, we found that the plasmids were also unstable at 28 °C in the absence of chloramphenicol, with a curing rate of up to 16/16 (100 %) after a round of seed culture and solid plate screening. The edited cells free of pBNVCm-sgRNA could thus be used for subsequent rounds of gene editing.

Fig. 5.

Fig. 5

A schematic diagram showing the iterative genome editing protocol for R. opacus. After a round of genome editing, selected cells were cultured in seed medium and spread on plates containing kanamycin to cure plasmid pBNVCm-sgRNA for the next round of editing. The final edited colonies were grown on antibiotic-free plates to simultaneously cure the two plasmids.

In the case of the pNV-PBAD-D-Pniami-Cas9 plasmid, although no temperature-sensitive replicons were available, the plasmid had a low copy number and was unstable in the absence of kanamycin owing to the burden caused by the recombinase and Cas9. Both pBNVCm-sgRNA and pNV-Pbad-D-Pniami-Cas9 could be simultaneously cured at 28 °C to obtain the final edited strain free of plasmids.

4. Discussions

The PD630 strain of R. opacus represents a promising vehicle for lignin bioconversion, and in this respect has attracted considerable attention in recent years [28]. However, despite the development of CRISPR-based interference systems for gene repression in R. opacus, a CRISPR/Cas9 system for gene knockout in this strain has yet to be reported. Moreover, although a CRISPR/Cas9-based dsDNA recombineering system has been effectively established for another Rhodococcus species (R. ruber) [15], this procedure proved to be untransferable to R. opacus, owing to the cytotoxicity of Cas9, as well as limited dsDNA recombineering efficiency of recombinases Che9c60 and Che9c61.

We found that overexpression of Cas9 driven by the same Pa2 promoter had markedly differing effects on the growth of R. opacus and R. ruber, thereby indicating the substantial genetic differences between these two Rhodococcus species. The cytotoxic effect of overexpressed Cas9 on R. opacus in the absence of sgRNA is consistent with the previous findings of studies on C. glutamicum [29], Halomonas spp. [30], and Mycobacterium smegmatis [27]. Strategies including fine-tuning the expression of Cas9 and selecting alternative Cas effectors, such as Cas12a, have been proposed to eliminate this problem [27,31]. However, given that Cas12a utilizes T-rich PAM sites [32], compared with Cas9, there are fewer potential editing targets in R. opacus, in which the genome GC content can be up to 67 %. Consequently, we prioritized Cas9 when developing a CRISPR system for R. opacus, and subsequently established that driving the expression of Cas9 with a weak promoter is an effective strategy for reducing cytotoxicity.

To compensate for the limited endogenous DSB repair pathway of prokaryotes, bacteriophage recombinases have often been introduced to enhance the efficiency of recombination. On the basis of our screening of candidate recombinases, we identified a novel recombinase, RrRecT, derived from an R. ruber prophage, the use of which facilitated the incorporation of short ssDNAs (as short as 60 nt) to generate recombinants in R. opacus. A strong bias toward ssDNA targeting the lagging strand was also observed. Compared with the previously reported Che9c61 recombinase derived from mycobacteriophages, the efficiency of RrRecT was 10-fold higher, indicating that it is a reliable strategy to screen recombinases from the phages or prophages of phylogenetically related species. Even so, however, compared with Redβ or RecT used for E. coli [16], the efficiency of RrRecT was still not high enough with respect to R. opacus. Therefore, we anticipate that more effective recombinases will be identified or that engineering of the RrRecT based on directed evolution/rational design could be applied to further enhance the efficiency of ssDNA recombineering in R. opacus.

By coupling ssDNA recombineering with CRISPR/Cas9-based counter-selection, we succeeded in developing a two-plasmid genome editing system for R. opacus. Compared with the triple-plasmid CRISPR/Cas9-based dsDNA recombination system used for R. ruber [15], the two-plasmid system proved to be more convenient, by virtue of simplifying the procedure of plasmid transformation and requiring only short oligonucleotides (60–80 nt). The system was found to be efficient with respect to gene disruption and point mutation, with editing efficiencies ranging from 22 % to 100 %. We also established the feasibility of single-step double gene disruption, albeit at a relatively low efficiency (approximately 4 %). Unfortunately, the system is inefficient for long fragment deletion or integration. To address this problem, a dsDNA recombineering system might be established in the future by introducing the corresponding exonuclease RrRecE complementary to RrRecT.

5. Conclusions

In this study, we revealed that the cytotoxicity of Cas9 and inefficient pathways for DNA double-strand break repair represent major obstacles with respect to developing a CRISPR/Cas9 genome editing system for use in R. opacus. By fine-tuning the expression of Cas9 using a weak promoter, we succeeded in reducing its cytotoxicity and established CRISPR/Cas9-mediated counter-selection in R. opacus. Furthermore, by screening candidate recombinases, we identified the novel recombinase RrRecT, which could be applied in ssDNA recombineering and effectively enhance the recombination efficiency of R. opacus. Finally, by coupling RrRecT-assisted ssDNA recombineering with CRISPR/Cas9 counter-selection, we successfully developed an efficient and scarless genome editing system for R. opacus. We anticipate that this system will facilitate the engineering of R. opacus to yield superior strains for the production of value-added biochemicals and biofuels from renewable biomass.

CRediT authorship contribution statement

Youxiang Liang: Methodology, Investigation, Writing – original draft. Yuwen Wei: Methodology, Resources. Song Jiao: Methodology, Resources. Huimin Yu: Conceptualization, Writing – review & editing, Supervision, Project administration, Funding acquisition.

Declaration of competing interest

The authors declare that they have no conflict of interest.

Acknowledgement

This work was supported by the National Key R&D Program of China (2018YFA0902200) and Natural Science Foundation of China (No. 21776157; No. 22078173). We thank Professor Jun Ishikawa (Japan) for supplying plasmid pNV18.1.

Footnotes

Peer review under responsibility of KeAi Communications Co., Ltd.

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.synbio.2021.08.001.

Appendix A. Supplementary data

The following is the Supplementary data to this article:

Multimedia component 1
mmc1.docx (3.6MB, docx)

References

  • 1.Xie S., Sun S., Lin F. Mechanism‐Guided design of highly efficient protein secretion and lipid conversion for biomanufacturing and biorefining. Advanced Science. 2019;6(13):1801980. doi: 10.1002/advs.201801980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kim H.M., Chae T.U., Choi S.Y. Engineering of an oleaginous bacterium for the production of fatty acids and fuels. Nat Chem Biol. 2019;15(7):721–729. doi: 10.1038/s41589-019-0295-5. [DOI] [PubMed] [Google Scholar]
  • 3.Cai C., Xu Z., Xu M. Development of a Rhodococcus opacus cell factory for valorizing lignin to muconate. ACS Sustainable Chem Eng. 2020;8(4):2016–2031. [Google Scholar]
  • 4.Yoneda A., Henson W.R., Goldner N.K. Comparative transcriptomics elucidates adaptive phenol tolerance and utilization in lipid-accumulating Rhodococcus opacus PD630. Nucleic Acids Res. 2016;44(5):2240–2254. doi: 10.1093/nar/gkw055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kurosawa K., Boccazzi P., de Almeida N.M. High-cell-density batch fermentation of Rhodococcus opacus PD630 using a high glucose concentration for triacylglycerol production. J Biotechnol. 2010;147(3–4):212–218. doi: 10.1016/j.jbiotec.2010.04.003. [DOI] [PubMed] [Google Scholar]
  • 6.DeLorenzo D.M., Rottinghaus A.G., Henson W.R. Molecular toolkit for gene expression control and genome modification in Rhodococcus opacus PD630. ACS Synth Biol. 2018;7(2):727–738. doi: 10.1021/acssynbio.7b00416. [DOI] [PubMed] [Google Scholar]
  • 7.DeLorenzo D.M., Henson W.R., Moon T.S. Development of chemical and metabolite sensors for Rhodococcus opacus PD630. ACS Synth Biol. 2017;6(10):1973–1978. doi: 10.1021/acssynbio.7b00192. [DOI] [PubMed] [Google Scholar]
  • 8.DeLorenzo D.M., Moon T.S. Construction of genetic logic gates based on the T7 RNA polymerase expression system in Rhodococcus opacus PD630. ACS Synth Biol. 2019;8(8):1921–1930. doi: 10.1021/acssynbio.9b00213. [DOI] [PubMed] [Google Scholar]
  • 9.Desomer J., Crespi M., Van Montagu M. IIIegitimate integration of non-replicative vectors in the genome of Rhodococcus fascians upon electro-transformation as an insertional mutagenesis system. Mol Microbiol. 1991;5(9):2115–2124. doi: 10.1111/j.1365-2958.1991.tb02141.x. [DOI] [PubMed] [Google Scholar]
  • 10.van Kessel J.C., Hatfull G.F. Recombineering in Mycobacterium tuberculosis. Nat Methods. 2007;4(2):147–152. doi: 10.1038/nmeth996. [DOI] [PubMed] [Google Scholar]
  • 11.Cong L., Ran F.A., Cox D. Multiplex genome engineering using CRISPR/cas systems. Science. 2013;339(6121):819–823. doi: 10.1126/science.1231143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Jiang W., Bikard D., Cox D. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol. 2013;31(3):233–239. doi: 10.1038/nbt.2508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ran F.A., Hsu P.D., Wright J. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281–2308. doi: 10.1038/nprot.2013.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Qi L.S., Larson M.H., Gilbert L.A. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013;152(5):1173–1183. doi: 10.1016/j.cell.2013.02.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Liang Y., Jiao S., Wang M. A CRISPR/Cas9-based genome editing system for Rhodococcus ruber TH. Metab Eng. 2020;57:13–22. doi: 10.1016/j.ymben.2019.10.003. [DOI] [PubMed] [Google Scholar]
  • 16.Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000;97(12):6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kusano K., Takahashi N.K., Yoshikura H. Involvement of RecE exonuclease and RecT annealing protein in DNA double-strand break repair by homologous recombination. Gene. 1994;138(1–2):17–25. doi: 10.1016/0378-1119(94)90778-1. [DOI] [PubMed] [Google Scholar]
  • 18.Filsinger G.T., Wannier T.M., Pedersen F.B. Characterizing the portability of phage-encoded homologous recombination proteins. Nat Chem Biol. 2021;17(4):394–402. doi: 10.1038/s41589-020-00710-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.van Pijkeren J., Britton R.A. High efficiency recombineering in lactic acid bacteria. Nucleic Acids Res. 2012;40(10):e76. doi: 10.1093/nar/gks147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chiba K., Hoshino Y., Ishino K. Construction of a pair of practical Nocardia-Escherichia coli shuttle vectors. Jpn J Infect Dis. 2007;60(1):45–47. [PubMed] [Google Scholar]
  • 21.Jakoby M., Ngouoto-Nkili C., Burkovski A. Construction and application of new Corynebacterium glutamicum vectors. Biotechnol Tech. 1999;13(6):437–441. [Google Scholar]
  • 22.Jeongbin P., Sangsu B., Jin-Soo K. Cas-Designer: a web-based tool for choice of CRISPR-Cas9 target sites. Bioinformatics. 2015;(24):4014. doi: 10.1093/bioinformatics/btv537. [DOI] [PubMed] [Google Scholar]
  • 23.Kalscheuer R., Arenskötter M., Steinbüchel A. Establishment of a gene transfer system for Rhodococcus opacus PD630 based on electroporation and its application for recombinant biosynthesis of poly(3-hydroxyalkanoic acids) Appl Microbiol Biotechnol. 1999;52(4):508–515. doi: 10.1007/s002530051553. [DOI] [PubMed] [Google Scholar]
  • 24.Jiao S., Yu H., Shen Z. Core element characterization of Rhodococcus promoters and development of a promoter-RBS mini-pool with different activity levels for efficient gene expression. N Biotech. 2018;44:41–49. doi: 10.1016/j.nbt.2018.04.005. [DOI] [PubMed] [Google Scholar]
  • 25.Henson W.R., Campbell T., DeLorenzo D.M. Multi-omic elucidation of aromatic catabolism in adaptively evolved Rhodococcus opacus. Metab Eng. 2018;49:69–83. doi: 10.1016/j.ymben.2018.06.009. [DOI] [PubMed] [Google Scholar]
  • 26.Cui Y., Dong H., Ma Y. Strategies for applying nonhomologous end joining-mediated genome editing in prokaryotes. ACS Synth Biol. 2019;8(10):2194–2202. doi: 10.1021/acssynbio.9b00179. [DOI] [PubMed] [Google Scholar]
  • 27.Sun B., Yang J., Yang S. A CRISPR-cpf1-assisted non-homologous end joining genome editing system of Mycobacterium smegmatis. Biotechnol J. 2018;13(9):1700588. doi: 10.1002/biot.201700588. [DOI] [PubMed] [Google Scholar]
  • 28.Chatterjee A., DeLorenzo D.M., Carr R. Bioconversion of renewable feedstocks by Rhodococcus opacus. Curr Opin Biotechnol. 2020;64:10–16. doi: 10.1016/j.copbio.2019.08.013. [DOI] [PubMed] [Google Scholar]
  • 29.Jiang Y., Qian F., Yang J. CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum. Nat Commun. 2017;8(1) doi: 10.1038/ncomms15179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Qin Q., Ling C., Zhao Y. CRISPR/Cas9 editing genome of extremophile Halomonas spp. Metab Eng. 2018;47(January):219–229. doi: 10.1016/j.ymben.2018.03.018. [DOI] [PubMed] [Google Scholar]
  • 31.Liu J., Wang Y., Lu Y. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum. Microb Cell Factories. 2017;16(1) doi: 10.1186/s12934-017-0815-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zetsche B., Gootenberg J.S., Abudayyeh O.O. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-cas system. Cell. 2015;163(3):759–771. doi: 10.1016/j.cell.2015.09.038. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (3.6MB, docx)

Articles from Synthetic and Systems Biotechnology are provided here courtesy of KeAi Publishing

RESOURCES